Curis | CRIS - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Alaunos Therapeutics USD 1.29M 865K 2026-03
Amgen USD 11.69B 2.5B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Bayer EUR 29.71B 863M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
CSL USD 18.66B 2.75B 2025-12
Curis USD 12.71M 7.24M 2026-03
Eli Lilly USD 33.88B 2.68B 2026-06
Exelixis USD 1.84B 91.99M 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Merck USD 41.93B 3.94B 2026-06
Novartis USD 41.95B 3.02B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Takeda JPY 7.56T 215.7B 2026-06
TG Therapeutics USD 604.08M 20.95M 2026-06
Verastem USD 81.78M 24.58M 2026-03